Republic Healthcare Limited

Republic Healthcare Limited

HHKEX:8357
0.20
HKD
0.00
(0.00%)
56.58MMarket Cap
Republic Healthcare Limited
HKEX:8357
(Hong Kong Exchange)

Recent

price

0.20

P/E

ratio

- -

div

yld

- -

ROIC.AI

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
SGD
0.01
0.02
0.02
0.03
0.03
0.02
0.01
0.02
0.01
0.01
- -
Revenue per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Basic EPS, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
-0.01
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
0.02
0.03
0.03
0.02
0.02
0.02
0.02
0.02
0.02
Book Value per Share
- -
- -
0.02
0.03
0.03
0.02
0.02
0.02
0.02
0.02
0.02
Tangible Book Value per Share
520
520
461
520
520
551
624
624
624
624
624
Basic Weighted Avg Shares
7
10
10
13
14
13
9
10
9
8
- -
Sales/Revenue/Turnover
32.43
24.69
-7.58
7.96
-3.49
-10.23
-14.92
-8.77
-9.87
-39.55
- -
Operating Margin (%)
- -
- -
- -
1
1
2
1
1
1
1
- -
Depreciation Expense
2
2
-1
1
- -
-1
-1
-1
- -
-3
- -
Net Income, GAAP
13.09
1.98
- -
42.01
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
27.71
20.16
-7.01
4.74
-1.05
-7.47
-16.42
-8.55
-2.06
-37.79
- -
Profit Margin (%)
1
1
12
12
11
14
12
11
11
7
12
Working Capital
- -
- -
- -
2
2
1
- -
- -
- -
4
- -
LT Debt
2
2
13
13
13
15
14
13
13
10
13
Total Equity
- -
116.91
- -
4.23
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
122.57
- -
4.97
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
112.08
-10.24
4.94
-1.09
-7.09
-10.34
-6.49
-1.41
-27.21
- -
Return on Common Equity (%)

Capital Structure

SGD

•

in mil. unless spec.
Sep'23
Dec'23
Jun'24
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
624
624
624
Market Capitalization
12
10
10

Working Capital

SGD

•

in mil. unless spec.
Sep'23
Dec'23
Jun'24
Total Current Assets
- -
14
14
Cash, Cash Equivalents & STI
- -
12
10
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
1
- -
Total Current Liabilities
- -
2
2
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

SGD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
-5.18%
-23.92%
Free Cash Flow
- -
1,117.48%
-6,629.43%
Net Income, GAAP
- -
421.97%
1,587.74%
Sales/Revenue/Turnover
- -
-9.17%
-8.08%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

SGD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
9
2025
- -
- -
8
2026
- -
- -
- -

Semi-annual Earnings Per Share

SGD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
- -
2025
- -
- -
- -
2026
- -
- -
- -

Semi-annual Dividends Per Share

SGD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
- -
2025
- -
- -
- -
2026
- -
- -
- -
Business
Republic Healthcare Limited (8357.HK), an investment holding company, operates a network of medical clinics under the Dr. Tan & Partners (DTAP) brand and provides primary healthcare services in Singapore. The company offers consultation, medical investigation, and treatment services focused on sexual health for men and women, men's health including andrology, women's health encompassing sexual function, aging, fertility, and female wellness; general practice services such as chronic disease management, laser testing, allergy prevention, skin rejuvenation, discreet STD testing, health screenings, vaccinations, and cancer marker tests; management consultancy services; online and wholesale trade of goods; wholesale of medical, professional, scientific, and precision equipment; and educational support services including healthcare-related education through direct-to-consumer outreach, social media, and partnerships with universities in the Philippines and other countries for joint degree programs and certifications. Founded in 2010 and headquartered at 201 Henderson Road, #07-11/12 Apex @ Henderson, Singapore, with its registered office in the Cayman Islands and a principal place of business in Hong Kong, Republic Healthcare primarily serves patients in Singapore and Asia, targeting individuals seeking specialized sexual health, men's health, women's health, and general primary care. Recent developments include strategic expansion of the DTAP clinic network with a new clinic in Jurong involving tenancy agreements and renovations; establishment of a new online business line and SA Clinics; a strategic cooperation agreement entered on December 19, 2024, with Shenzhen R. Lifenergy Co., Ltd. for collaboration in cell, gene, and microbiota biotechnology products and services, healthcare-related education, professional training, and development of Life’s Ark health management institutions targeting Southeast Asia and international markets; and an acquisition of property announced in March 2025, with completion expected by April 2025 to support business growth.